Eczema medical therapy

Revision as of 01:06, 22 June 2022 by Edzelco (talk | contribs) (/* 2014 Clinical Practice Guidelines for the Management of Eczema by American Academy of Dermatology {{cite journal| author=Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K | display-authors=etal| title=Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. | journal=J Am Acad Dermatol | year= 2014 | volume= 71 | issue= 1 | pages= 116-32 | pmid=24813302 | doi=10.1016/j.jaad.2014.03.023...)
Jump to navigation Jump to search

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Topical corticosteroids are the mainline treatment for eczema. Different potencies of steroids are rendered specifically for the severity of eczema. Other drug treatments often used for eczema include topical calcineurin inhibitors, crisaborole, antimicrobials, and antifungals.

Medical Therapy

Pharmacotherapy

  • Moisturizers
    • Eczema can be exacerbated by dryness of the skin.
    • Moisture content is the main factor that determines the occurrence of eczema.
    • European emollients such asOilatum, Balneum, Medi Oil, Diprobase, Sebexol, Epaderm ointment, Eucerin lotion, bath oils and aqueous cream can relieve eczema itchiness.
    • Topical application of sulfur gains popularity as an alternative treatment to steroids. However, no evidence-based publications are available yet on this matter. [1]

Light therapy

Herbal Medicine

Some of these topical remedies include:

2014 Clinical Practice Guidelines for the Management of Eczema by American Academy of Dermatology [7]

Class A
"1.Use of moisturizers. (Level of Evidence: I) "
"2.Use of topical corticosteroids. (Level of Evidence: I) "
"2a.Need for consideration of side effects with use. (Level of Evidence: I) "
"3.Use of topical calcineurin inhibitors (Level of Evidence: I) "
"3a.Use of topical calcineurin inhibitors (Level of Evidence: I) "

References

  1. "Sulfur". University of Maryland Medical Center. 4/1/2002. Retrieved 2007-10-15. Check date values in: |date= (help)
  2. Hoare C, Li Wan Po A, Williams H (2000). "Systematic review of treatments for atopic eczema". Health technology assessment (Winchester, England). 4 (37): 1–191. PMID 11134919.
  3. Atherton DJ (2003). "Topical corticosteroids in atopic dermatitis". BMJ. 327 (7421): 942–3. doi:10.1136/bmj.327.7421.942. PMID 14576221.
  4. Lee NP, Arriola ER (1999). "Topical corticosteroids: back to basics" ("Scanned & PDF"). West. J. Med. 171 (5–6): 351–3. PMID 10639873.
  5. Martins GA, Arruda L (2004). "Systemic treatment of psoriasis - Part I: methotrexate and acitretin". An. Bras. Dermatol (in English translation). 79 (3): 263–278. Unknown parameter |month= ignored (help)
  6. Stern RS (2001). "The risk of melanoma in association with long-term exposure to PUVA". J. Am. Acad. Dermatol. 44 (5): 755–61. doi:10.1067/mjd.2001.114576. PMID 11312420.
  7. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K; et al. (2014). "Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies". J Am Acad Dermatol. 71 (1): 116–32. doi:10.1016/j.jaad.2014.03.023. PMC 4326095. PMID 24813302.